CareSource deems 1st year of enrollments a success — 5 observations

CareSource, the second company in West Virginia to offer health insurance plans on the state’s marketplace created in the ACA, is deeming the first year of enrollment successful, according to MetroNews.

Advertisement

Here are five observations:

1. First-year enrollments are 20 percent higher than CareSource had estimated.

2. Dayton, Ohio-based CareSource had more than 1,800 West Virginians sign up for health insurance.

3. The company is offering plans in 10 West Virginia counties including Brooke, Cabell, Hancock, Kanawha, Lincoln, Marshall, Mason, Ohio, Putnam and Wayne. The company also operates in Kentucky, Ohio and Indiana.

4. 2016 is the first year state residents in those 10 counties have other insurance options aside from health insurance plans offered through Highmark Blue Cross Blue Shield

5. Nearly 13 million people enrolled for health plans through the ACA during the third open enrollment period.

More articles on coding & billing:
Healthcare enrollment exceeds expectations — 5 points
Massachusetts payers discuss 3 healthcare issues
North Carolina commissioner unhappy with ACA: 3 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Coding, Billing & Collections

Advertisement

Comments are closed.